Gene-editing technique CRISPR identifies dangerous breast cancer
4.6 (791) · $ 6.50 · In stock
Mutations in BRCA genes are linked to the early onset of breast and ovarian cancers. But the effect of most mutations is unclear. Now new research can distinguish harmless from dangerous mutations.
CRISPR/Cas9: A powerful genome editing technique for the treatment of cancer cells with present challenges and future directions - ScienceDirect
Teaming Up Two Biotech Winners to Fight Cancer: CRISPR and CAR T
Elixir
CRISPR – News, Research and Analysis – The Conversation – page 4
BRCA1 – News, Research and Analysis – The Conversation – page 1
How CRISPR Is Changing Cancer Research and Treatment - NCI
Ovarian cancer – News, Research and Analysis – The Conversation – page 1
WHAT IS CRISPR-CAS9?
Early-onset cancer – News, Research and Analysis – The Conversation – page 1
COVID-19 variants – News, Research and Analysis – The Conversation – page 7
